Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Controlled Phase IV Study to Compare Bioseal Versus Standard of Care as an Adjunct to Hemostasis in Elective Brain Tumor Surgery

NCT02034799 is registered in ClinicalTrials.gov with Ethicon, Inc. as lead sponsor.

NCT NCT02034799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02034799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Controlled Phase IV Study to Compare Bioseal Versus Standard of Care as an Adjunct to Hemostasis in Elective Brain Tumor Surgery
Lead sponsor
Ethicon, Inc.
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2013
Completion date
September 1, 2014
Enrollment
256 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hemostasis, meningioma surgery